ArticleAmerican journal of nephrology2026

Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Guson Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.